The right time and place: the need for seven‐day pharmacist service models

Systematic review of machine learning models for personalised dosing of heparin

Evaluation of the Collaborative Ordering of Medications (COOM) pharmacist-physician model of care at the point of discharge in a digital hospital

Determining causality, severity and preventability of inpatient medication harm, including related hospital-acquired complications, using clinical coding data

Medicinal mishap: death from diltiazem-ibrutinib interaction

The pharmacist informatician: providing an innovative model of care during the COVID-19 crisis

Development and validation of the Adverse Inpatient Medication Event Model (AIME)

Prioritising patients at high-risk of medication harm: development and validation of risk prediction models

Vitamin D and the link with Parkinson’s disease: causal or correlational?

Identifying medication harm in hospitalised patients: a bimodal, targeted approach

How hospital pharmacists prioritise patients at high-risk for medication harm

Defining and classifying terminology for medication harm: a call for consensus

Prioritising hospital patients at high-risk of medication harm: development and validation of a predictive risk model

Reply to Iuga and Genaidy "Comment on Falconer et al. (2018) - the need for specific adverse drug reaction outcomes"

Systematic review of predictive risk models for adverse drug events in hospitalised patients

Validation of the assessment of risk tool: patient prioritisation technology for clinical pharmacist interventions

Rethinking how we speak with patients about their medicine- there's more than one way to skin a CAT

Identifying Clinical Pharmacist Patient Prioritisation Criteria

Educating pharmacy students to speak with patients about their medications - a novel use of CAT

Identifying inpatients at high risk of adverse drug events: Systematic review of predictive risk scores